RECKITT & COLMAN PLC
27 August 1999
Reckitt & Colman plc
Results of Extraordinary General Meeting
Both resolutions for proposed merger with Benckiser N.V.
approved by
Reckitt & Colman shareholders
At the Extraordinary General Meeting of Reckitt & Colman
held today, both the ordinary resolutions set out in the
circular to shareholders dated 11 August 1999 were passed
thereby giving consent to the merger between Reckitt &
Colman and Benckiser.
The first closing date for the offer for Benckiser B
shares will be on 8 September 1999. As set out in full
in the documentation sent to shareholders on 11 August
1999 the offer is conditional upon, amongst other things,
the relevant merger regulation consents from the European
Commission and the relevant authorities in the United
States.
Alan Dalby, Chairman of Reckitt & Colman commented:
'We are very pleased to receive shareholder approval for
the merger of Reckitt & Colman and Benckiser. We see a
major opportunity for the creation of value and long term
growth, for a group with global scale. This is an
excellent combination of two complementary businesses.'
Enquiries:
Reckitt & Colman
David Saltmarsh 01753 746676
Shandwick
Bobby Leach 0171 329 0096
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.